Patents by Inventor Richard Keon

Richard Keon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090282583
    Abstract: Commercial production of human insulin can be effected via transgenic expression in plant seeds. Thus, levels of insulin accumulation exceeding 0.1% of total cellular protein can be achieved recombinantly, through expression of the insulin with a single-chain antibody as a fusion partner. Production in seeds offers flexibility in storage and shipment of insulin as a raw material, and insulin retains its activity upon extraction from stored seed. Further, the amount of biomass subjected to extraction is limited, due to the relatively low water content of plant seeds.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 12, 2009
    Applicant: SEMBIOSYS GENETICS INC.
    Inventors: MAURICE M. MOLONEY, JOSEPH BOOTHE, RICHARD KEON, CORY NYKIFORUK, GIJS VAN ROOIJEN
  • Patent number: 7547821
    Abstract: Commercial production of human insulin can be affected via transgenic expression in plant seeds. Thus, levels of insulin accumulation exceeding 0.1% of total cellular protein can be achieved recombinantly, through expression of the insulin with a single-chain antibody as a fusion partner. Production in seeds offers flexibility in storage and shipment of insulin as a raw material, and insulin retains its activity upon extraction from stored seed. Further, the amount of biomass subjected to extraction is limited, due to the relatively low water content of plant seeds.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: June 16, 2009
    Assignee: SemBioSys Genetics Inc.
    Inventors: Maurice M. Moloney, Joseph Boothe, Richard Keon, Cory Nykiforuk, Gijs Van Rooijen
  • Publication number: 20050039235
    Abstract: Methods for the production of insulin in plants are described. In one embodiment, the present invention provides a method for the expression of insulin in plants comprising: (a) providing a chimeric nucleic acid construct comprising in the 5? to 3? direction of transcription as operably linked components: (i) a nucleic acid sequence capable of controlling expression in plant seed cells; and (ii) a nucleic acid sequence encoding an insulin polypeptide; (b) introducing the chimeric nucleic acid construct into a plant cell; and (c) growing the plant cell into a mature plant capable of setting seed wherein the seed expresses insulin.
    Type: Application
    Filed: June 17, 2004
    Publication date: February 17, 2005
    Inventors: Maurice Moloney, Joseph Boothe, Richard Keon, Cory Nykiforuk, Gijs Van Rooijen
  • Patent number: 5046392
    Abstract: A method and apparatus for severing a length of insulating batting and simultaneously cutting only the insulating material thereof is provided. The insulating material between the severed edge of the insulation batting and the cutting line through the insulating material can be removed to expose a length of backing which can be secured to the uncut portion of the insulation batting length when the insulation batting length is wrapped around a length of a heating and cooling duct or the like. The apparatus includes a pair of rotating cutting wheels rotatably mounted on a carriage movable along an elongate carriage rail. A pinion gear mounted to each rotating cutting wheel for rotation therewith meshes with a rack secured to the elongate carriage rail to cause rotation of the rotating cutting wheel in response to movement of the carriage along the carriage rail.
    Type: Grant
    Filed: April 6, 1989
    Date of Patent: September 10, 1991
    Inventors: Richard Keon, Luther Morris